These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38504266)

  • 1. Analysis of affordability differences for rare diseases in China: a comparison across disease types and regions.
    Chen Y; Chen X; Deng Y; Ding J
    Int J Equity Health; 2024 Mar; 23(1):64. PubMed ID: 38504266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the national system for rare diseases in China from the point of drug access: progress and challenges.
    Qiao L; Liu X; Shang J; Zuo W; Xu T; Qu J; Jiang J; Zhang B; Zhang S
    Orphanet J Rare Dis; 2022 Sep; 17(1):352. PubMed ID: 36088349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare costs for patients with rare diseases: Evidence from China.
    Zhang X; Dai L; Long Y; Chen X; Alhafi MAK
    Int J Health Plann Manage; 2024 Jan; 39(1):48-61. PubMed ID: 37815061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cross-Sectional Study of Price and Affordability of Drugs for Rare Diseases in Shandong Province, China.
    Mu Y; Song K; Song Y
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health service security of patients with 8 certain rare diseases: evidence from China's national system for health service utilization of patients with healthcare insurance.
    Min R; Zhang X; Fang P; Wang B; Wang H
    Orphanet J Rare Dis; 2019 Aug; 14(1):204. PubMed ID: 31429789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The availability and affordability of orphan drugs for rare diseases in China.
    Gong S; Wang Y; Pan X; Zhang L; Huang R; Chen X; Hu J; Xu Y; Jin S
    Orphanet J Rare Dis; 2016 Feb; 11():20. PubMed ID: 26920579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economic burden and factors associated with Crohn's disease].
    Zhou WP; Mu N; Jian WY; Wang HH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):555-559. PubMed ID: 34145860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is sub-national healthcare social protection sufficient for protecting rare disease patients? the case of China.
    Xu J; Yu M; Zhang Z; Gong S; Li B
    Front Public Health; 2023; 11():1198368. PubMed ID: 37397721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the performance of social health insurance system through increasing outpatient expenditure reimbursement ratio: a quasi-experimental evaluation study from rural China.
    Miao Y; Gu J; Zhang L; He R; Sandeep S; Wu J
    Int J Equity Health; 2018 Jun; 17(1):89. PubMed ID: 29940956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New cooperative medical scheme decreased financial burden but expanded the gap of income-related inequity: evidence from three provinces in rural China.
    Ma J; Xu J; Zhang Z; Wang J
    Int J Equity Health; 2016 May; 15():72. PubMed ID: 27142618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
    Zhu Y; Wang Y; Sun X; Li X
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the current status and influencing factors of cross-regional hospitalization services utilization by basic medical insurance participants in China - taking a central province as an example.
    Song T; Ma R; Zhang X; Lv B; Li Z; Guo M; Yuan M; Tang Z
    Front Public Health; 2023; 11():1246982. PubMed ID: 38164453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The availability, price and affordability of antidiabetic drugs in Hubei province, China.
    Gong S; Cai H; Ding Y; Li W; Juan X; Peng J; Jin S
    Health Policy Plan; 2018 Oct; 33(8):937-947. PubMed ID: 30215707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between an increased reimbursement cap for chronic disease coverage and healthcare utilization in China: an interrupted time series study.
    Shen M; He W; Yeoh EK; Wu Y
    Health Policy Plan; 2020 Oct; 35(8):1029-1038. PubMed ID: 32869090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in reimbursement listing of anticancer therapies in China: an observational study.
    Guan X; Zhang Y; Wushouer H; Shi L; Ross-Degnan D; Wagner AK
    BMJ Open; 2020 Jan; 10(1):e031203. PubMed ID: 31911513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated annual prevalence, medical service utilization and direct costs of lung cancer in urban China.
    Zhu D; Shi X; Nicholas S; Ma Y; He P
    Cancer Med; 2021 Apr; 10(8):2914-2923. PubMed ID: 33749141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of health insurance on direct hospitalisation costs for in-patients with ischaemic stroke in China.
    Yong M; Xianjun X; Jinghu L; Yunyun F
    Aust Health Rev; 2018 Feb; 42(1):39-44. PubMed ID: 28263706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Access to Orphan Drugs Covered by Medical Insurance in China: Real-World Evidence From Patient Survey.
    Wang X; Li SC; Yue X; Li Y; Shi N; Zhao FL; Wu J
    Value Health Reg Issues; 2023 Mar; 34():71-77. PubMed ID: 36587572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constructing a value-based healthcare system for hypertensive patients through changing payment mode: evidence from a comparative study in rural China.
    Miao Y; Yuan X; Gu J; Zhang L; He R; Sandeep S; Wu J
    J Med Econ; 2019 Mar; 22(3):245-251. PubMed ID: 30547700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China.
    Xiong X; Zhang Z; Ren J; Zhang J; Pan X; Zhang L; Gong S; Jin S
    PLoS One; 2018; 13(3):e0193273. PubMed ID: 29513712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.